How does your module-based mapping service compare to standard whole transcriptome sequencing assays?

Our platform reduces biological noise by grouping transcripts into functional core and modifier modules, cross-referenced with quantitative protein level validation to map actual pathways.

We are working on non-kinase membrane receptors. Can your platform map these developmental pathways?

Yes, we track receptor cleavage fragments, downstream transcriptional endpoint signatures, and nuclear translocation kinetics to map Wnt, Notch, and Hedgehog non-kinase cascades very accurately.

What are the sample storage and shipping precautions we must follow when sending specimens to Creative Biolabs?

Frozen tissues and cells must be snap frozen in liquid nitrogen and shipped on dry ice, whereas FFPE slides are safely shipped at ambient temperatures.

Advanced & Integrative Cancer Signaling Pathway Mapping Services

In the highly competitive landscape of oncology drug discovery, validating a therapeutic target requires more than confirming its genomic sequence. Creative Biolabs provides functional, high-resolution network insights that bridge the gap between genotype and phenotype. By mapping the activation state of core signaling hubs and metabolic-sensing networks, we enable your team to confirm on-target engagement, predict resistance mechanisms early, and systematically discover synergistic combination therapy targets.

Background and Scientific Rationale of Pathway Mapping

Advanced signaling pathway mapping has emerged as a cornerstone of precision oncology, addressing the critical limitation where static genetic mutations rarely dictate therapeutic outcomes in isolation. Because genetic alterations propagate through highly redundant, interconnected molecular cascades that dynamically rewire within the tumor microenvironment, this systems biology framework models functional, network-level activation rather than static protein states. By computing aggregated activity indices across core signaling cascades and feedback loops, it mathematically resolves where genetic aberrations converge and where downstream survival signals diverge under drug selection pressure. This empowers researchers to intercept cellular escape mechanisms and systematically identify synergistic multi-target combinations.

Specialized Capabilities

To support your target validation and lead optimization pipelines, Creative Biolabs offers a diverse portfolio of customizable molecular mapping panels and computational services:

Single-Cell Mapping

Creative Biolabs provides single-cell pathway mapping, quantifying intracellular signaling cascades within the tumor microenvironment. We utilize scRNA-seq and spatial transcriptomics to evaluate compensatory crosstalk, cell fate bifurcations, and resistance mechanisms.

Learn More →

Spatial Omics Analysis

Creative Biolabs provides spatial omics analysis, quantifying protein localization and tumor microenvironment architectural mapping. We utilize multiplex spatial profiling to evaluate cancer signaling pathway crosstalk, stromal-immune architecture, and localized target engagement.

Learn More →

Multi-Omics Integration & Visualization

Creative Biolabs provides multi-omics integration and visualization services, quantifying cancer signaling pathway networks. We utilize advanced computational frameworks to evaluate genomic, transcriptomic, and proteomic datasets, transforming multi-layer molecular flux into high-resolution, interactive pathway maps.

Learn More →

Biomarker & Therapeutic Target Discovery

Creative Biolabs provides biomarker and therapeutic target discovery services, quantifying cancer signaling pathway alterations. We utilize high-throughput multi-omic networks to evaluate novel oncogenic drivers and pre-clinical mechanisms of action.

Learn More →

Epigenetic & microRNA Regulation Analysis

Creative Biolabs provides epigenetic and microRNA regulation analysis, quantifying chromatin modifications and non-coding RNA profiles. We utilize high-throughput profiling platforms to evaluate cancer signaling pathways, transcriptional dynamics, and pre-clinical target efficacy.

Learn More →

Connect with a Specialist: Request a Customized Technical Project Consultation & Tailored Protocol Evaluation Today

Workflow

Our end-to-end service transforms raw biological samples into comprehensive, publication-ready pathway maps through a standardized and highly optimized molecular pipeline.

Publication

This review examines basal cell carcinoma (BCC), the most common skin cancer, driven by aberrant Hedgehog (Hh) signaling due to PTCH or SMO mutations. It details current Hh pathway inhibitors (vismodegib, sonidegib) for advanced BCC, their limitations including resistance and adverse events, and emerging strategies such as second-generation SMO inhibitors, GLI antagonists, BET inhibitors, and the PD-1 inhibitor, offering perspectives on future therapeutic options.

Why Choose Us?

Creative Biolabs provides a systems biology platform delivering high-resolution interactome maps with unmatched signal resolution. Unlike standard panels measuring flat transcript abundance, our proprietary top-down stratification engine separates target networks into core modules and peripheral modifier networks. We validate these transcriptional insights through multiplexed phospho-protein quantification and dynamic assay systems, ensuring every mapped pathway alteration is biochemically active to eliminate costly false positives. Partnering with our team provides actionable, high-resolution datasets tailored to your compound's exact mechanism of action, significantly accelerating lead optimization and maximizing candidate pipeline success across pre-clinical oncology research programs.

Schedule a Discovery Assessment: Receive a Comprehensive Custom Project Design Proposal & Strategic Cost Estimation Instantly

FAQs

Customer Review

Related Services

To complement your signaling pathway mapping projects, Creative Biolabs offers several highly integrated upstream and downstream services:

Quality Control for In Vivo Assays

Creative Biolabs provides in vivo assay design and model validation, quantifying antitumor effects, dosing kinetics, and biological endpoints. We utilize standardized design strategies to evaluate sample sizing, randomization schemes, and therapeutic efficacy.

Learn More →

Glutathione Detection for Ferroptosis Prediction

Creative Biolabs provides glutathione-related assay development, quantifying GSH/GSSG balance, intracellular reactive oxygen species, and lipid peroxidation. We utilize high-throughput colorimetric and mass spectrometry platforms to evaluate covalent inhibitors, site identification, and ferroptosis-mediated therapeutic pathways.

Learn More →

How to Contact Creative Biolabs

Creative Biolabs' advanced and integrative cancer signaling pathway mapping services provide biopharmaceutical sponsors with the high-resolution, biologically validated network readouts required to de-risk lead optimization and maximize therapeutic efficacy. By integrating state-of-the-art multi-omics workflows, top-down module stratification, and dynamic metabolite-sensing networks, our platform converts biological complexity into actionable drug-discovery data.